The estimated Net Worth of Richard A Sandberg is at least $1.86 Million dollars as of 20 January 2023. Mr. Sandberg owns over 20,000 units of Oxford Immunotec Global PLC stock worth over $898,204 and over the last 20 years he sold OXFD stock worth over $844,220. In addition, he makes $122,193 as Independent Director at Oxford Immunotec Global PLC.
Sign up
Mr. Sandberg OXFD stock SEC Form 4 insiders trading
Richard has made over 23 trades of the Oxford Immunotec Global PLC stock since 2005, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of OXFD stock worth $15,600 on 20 January 2023.
The largest trade he's ever made was buying 20,000 units of Oxford Immunotec Global PLC stock on 20 January 2023 worth over $15,600. On average, Richard trades about 2,260 units every 123 days since 2004. As of 20 January 2023 he still owns at least 40,846 units of Oxford Immunotec Global PLC stock.
You can see the complete history of Mr. Sandberg stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Richard Sandberg biography
Richard A. Sandberg serves as Independent Director of the Company. He has played a principal role in starting and building a number of medical diagnostic companies including that of founder, chairman, chief executive officer, and chief financial officer of DIANON Systems Inc., a publicly traded oncology diagnostics company that was a pioneer in marketing new diagnostic technologies as a service rather than a product offering. He also served as chairman and chief financial officer of Lifecodes Corporation, a pioneer in DNA testing technology; chief financial officer and director of Matritech Inc., a publicly traded biotechnology company specializing in proteomic diagnostic products for the early detection of a variety of cancers; and as chief financial officer of Critical Diagnostics, Inc., a company specializing in developing new diagnostic tests for cardiology. He has also served as a director of North American Scientific Inc., a publicly held developer and marketer of radiation therapy products and systems for treating breast and prostate cancer, from 2005 to 2009 and as a director of Ethan Allen Interiors Inc., an international manufacturer and retailer of fine home furnishings, from 2003 to 2009. He continues to serve as Chairman, director and/or executive officer of multiple privately-held healthcare companies. Mr. Sandberg earned his bachelor’s degree in Business from Northwestern University and his Master of Business Administration from Harvard Business School.
What is the salary of Richard Sandberg?
As the Independent Director of Oxford Immunotec Global PLC, the total compensation of Richard Sandberg at Oxford Immunotec Global PLC is $122,193. There are 2 executives at Oxford Immunotec Global PLC getting paid more, with Peter Wrighton-Smith having the highest compensation of $2,151,490.
How old is Richard Sandberg?
Richard Sandberg is 77, he's been the Independent Director of Oxford Immunotec Global PLC since 2019. There are no older and 10 younger executives at Oxford Immunotec Global PLC.
What's Richard Sandberg's mailing address?
Richard's mailing address filed with the SEC is C/O PRECIPIO, INC., 4 SCIENCE PARK, NEW HAVEN, CT, 06511.
Insiders trading at Oxford Immunotec Global PLC
Over the last 11 years, insiders at Oxford Immunotec Global PLC have traded over $13,598,906 worth of Oxford Immunotec Global PLC stock and bought 47,600 units worth $549,576 . The most active insiders traders include James R Tobin, Peter Wrighton Smith, and Ronald Asbury Andrews. On average, Oxford Immunotec Global PLC executives and independent directors trade stock every 36 days with the average trade being worth of $536,006. The most recent stock trade was executed by Patrick J Balthrop on 20 May 2020, trading 4,000 units of OXFD stock currently worth $49,920.
What does Oxford Immunotec Global PLC's logo look like?
Complete history of Mr. Sandberg stock trades at Oxford Immunotec Global PLC, Grayscale Ethereum Mini Trust, and Precipio Inc
Oxford Immunotec Global PLC executives and stock owners
Oxford Immunotec Global PLC executives and other stock owners filed with the SEC include:
-
Peter Wrighton-Smith,
Chief Executive Officer, Director -
Matthew McLaughlin,
Chief Financial Officer -
Richard Sandberg,
Independent Director -
Patrick Balthrop,
Independent Chairman of the Board -
Herman Rosenman,
Independent Director -
James Tobin,
Independent Director -
Patricia Randall,
Independent Director -
Andrew Walton,
Independent Director -
Mark Klausner,
Independent Director -
Ronald Andrews,
Independent Director -
Janet Kidd,
General Counsel, Company Secretary -
Herm Rosenman,
-
Richard M. Altieri,
Chief Financial Officer -
Peter Edwardson,
Chief Operations Officer -
Stephen L Spotts,
Director -
Jeff R. Schroeder,
Chief Commercial Officer -
Richard Wenstrup,
Chief Medical Officer -
Stefan C Linn,
Chief Operating Officer -
Elizabeth M Keiley,
VP & General Counsel -
Lifesciences I, L.P.Clarus ...,
-
Leaf Ventures Ii, L.P.New L...,